Synthesis and in-vitro potency of novel quinazolinone-based vitronectin receptor antagonists.

被引：0

作者：

Lawson, EC ^{[1
]}

Costanzo, MJ ^{[1
]}

Hoekstra, WJ ^{[1
]}

Kinney, WA ^{[1
]}

Luci, DK ^{[1
]}

Maryanoff, BE ^{[1
]}

Wisnoski, D ^{[1
]}

Yabut, SC ^{[1
]}

Andrade-Gordon, P ^{[1
]}

Kauffman, JA ^{[1
]}

Santulli, R ^{[1
]}

机构：

[1] RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 222卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

78-MEDI

引用

页码：U652 / U653

页数：2

共 50 条

[11] Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity
Sonousi, Amr
Hassan, Rasha A.
Osman, Eman O.
Abdou, Amr M.
Emam, Soha H.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 2644 - 2659
[12] Biphenyls as potent vitronectin receptor antagonists.: Part 2:: Biphenylalanine ureas
Urbahns, K
Härter, M
Vaupel, A
Albers, M
Schmidt, D
Brüggemeier, U
Stelte-Ludwig, B
Gerdes, C
Tsujishita, F
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) : 1071 - 1074
[13] Novel adenosine all receptor antagonists.
Petter, RC
Kiesman, WF
Conlon, PR
Kumaravel, G
Ensinger, CL
Dowling, J
Peng, B
Smits, G
Jin, XW
Lutterodt, FA
Fu, K
LePage, D
Jayaraj, A
Gill, A
Costa, D
Wortham, K
Porter, K
Linden, J
Sullivan, G
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U79 - U79
[14] Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors of MurA
Hrast, Martina
Rozman, Kaja
Jukic, Marko
Patin, Delphine
Gobec, Stanislav
Sova, Matej
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (15) : 3529 - 3533
[15] Potency and in vitro metabolic stability relationships of lactam based NK2 antagonists.
Lewis, ML
Fox, DNA
Tommasini, I
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A101 - A101
[16] Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity
Schenkel, Laurie B.
Olivieri, Philip R.
Boezio, Alessandro A.
Deak, Holly L.
Emkey, Renee
Graceffa, Russell F.
Gunaydin, Hakan
Guzman-Perez, Angel
Lee, Josie H.
Teffera, Yohannes
Wang, Weiya
Youngblood, Beth D.
Yu, Violeta L.
Zhang, Maosheng
Gavva, Narender R.
Lehto, Sonya G.
Geuns-Meyer, Stephanie
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (06) : 2794 - 2809
[17] Biphenyls as potent vitronectin receptor antagonists.: Part 3:: Squaric acid amides
Urbahns, Klaus
Haerter, Michael
Albers, Markus
Schmidt, Delf
Stelte-Ludwig, Beatrix
Brueggemeier, Ulf
Vaupel, Andrea
Keldenich, Joerg
Lustig, Klemens
Tsujishita, Hideki
Gerdes, Christoph
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6151 - 6154
[18] PFA-100, a novel pharmacological tool characterization of antiplatelet potency of thromboxane receptor antagonists.
Dogné, JM
de Leval, X
Delarge, J
Neven, P
Rolin, S
David, JL
Fillet, G
Masereel, B
BLOOD, 1999, 94 (10) : 103B - 103B
[19] Synthesis and in vitro potency of some novel thiophene-based αvβ3 antagonists
Bubenik, M
Chan, L
Attardo, G
Bergeron, F
Poirier, C
Meerovitch, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B129 - B129
[20] Novel melanin concentrating hormone receptor antagonists.
Ma, VV
Balan, C
Tempest, PA
Hulme, C
Bannon, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U67 - U67

← 1 2 3 4 5 →